-
Congruence Therapeutics Appoints Frank Taffy as Chief Business Officer
23 Apr 2024 17:59 GMT
… ;Frank will be a tremendous asset at a time when Congruence … Director of Corporate Development at Life Technologies (now part of Thermo Fisher …
-
A versatile high-throughput assay based on 3D ring-shaped cardiac tissues generated from human induced pluripotent stem cell derived cardiomyocytes
27 Mar 2024 17:21 GMT
… two parameters represents a significant asset, as this proof-of-concept … was changed to RPMI-1640 (Life Technologies) supplemented with B27 without insulin … with RPMI 1640 without glucose (Life Technologies), supplemented by B27 with insulin …
-
LGR5 as a Therapeutic Target of Antibody-Functionalized Biomimetic Magnetoliposomes for Colon Cancer Therapy
23 Feb 2024 08:31 GMT
… TOP10 growing at 37 °C (Life Technologies, Invitrogen, Grand Island, NY, USA … /ACS.LANGMUIR.8B03109/ASSET/;IMAGES/LARGE…
-
David Bruning Named Chief Executive Officer of StageBio
12 Feb 2024 18:48 GMT
… KGaA of Darmstadt, Germany) and Life Technologies (a division of Invitrogen). He … firm with $3 billion of assets under management, dedicated to growth …